DK0410246T3 - Erythropoeitin (EPO)-peptider og derimod rettede antistoffer. - Google Patents

Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.

Info

Publication number
DK0410246T3
DK0410246T3 DK90113527T DK90113527T DK0410246T3 DK 0410246 T3 DK0410246 T3 DK 0410246T3 DK 90113527 T DK90113527 T DK 90113527T DK 90113527 T DK90113527 T DK 90113527T DK 0410246 T3 DK0410246 T3 DK 0410246T3
Authority
DK
Denmark
Prior art keywords
epo
antibodies
peptides
epitope
relates
Prior art date
Application number
DK90113527T
Other languages
Danish (da)
English (en)
Inventor
Mathias Dr Fibi
Werner Dr Stueber
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of DK0410246T3 publication Critical patent/DK0410246T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90113527T 1989-07-26 1990-07-14 Erythropoeitin (EPO)-peptider og derimod rettede antistoffer. DK0410246T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3924746A DE3924746A1 (de) 1989-07-26 1989-07-26 Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper

Publications (1)

Publication Number Publication Date
DK0410246T3 true DK0410246T3 (da) 1998-08-31

Family

ID=6385895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90113527T DK0410246T3 (da) 1989-07-26 1990-07-14 Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.

Country Status (13)

Country Link
US (2) US5106954A (fr)
EP (1) EP0410246B1 (fr)
JP (1) JP3155002B2 (fr)
KR (1) KR0175657B1 (fr)
AT (1) ATE161577T1 (fr)
AU (1) AU648506B2 (fr)
CA (1) CA2021912C (fr)
DE (2) DE3924746A1 (fr)
DK (1) DK0410246T3 (fr)
ES (1) ES2111524T3 (fr)
GR (1) GR3026096T3 (fr)
IE (1) IE902707A1 (fr)
PT (1) PT94813B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6932968B1 (en) * 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB2270695B (en) * 1992-09-18 1996-06-05 Oxford Res Support Co Ltd Antibodies that activate plasminogen in the manner of streptokinase
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
HUP9901069A2 (hu) * 1995-06-07 1999-07-28 Affymax Technologies, N.V. Az eritropoietin receptorhoz kötődő vegyületek és peptidek
KR100400637B1 (ko) * 1996-02-06 2004-03-10 씨제이 주식회사 생물학적으로유용한펩타이드
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
TR200001580T2 (tr) * 1997-12-03 2000-12-21 Roche Diagnostics Gmbh Spesifik etkinliği yüksek eritropoyetin
KR100524041B1 (ko) * 1999-05-07 2005-10-27 제넨테크, 인크. 신규 침팬지 에리쓰로포이에틴 (chepo) 폴리펩티드 및 이를 코딩하는 핵산
IL145785A0 (en) * 1999-05-07 2002-07-25 Genentech Inc Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
US6831060B2 (en) 1999-05-07 2004-12-14 Genentech, Inc. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
US6703480B1 (en) 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
US7312089B2 (en) * 2000-04-05 2007-12-25 Jong Y. Lee Detection of erythropoietin and erythropoietin receptor
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2405557C (fr) 2000-04-12 2013-09-24 Human Genome Sciences, Inc. Proteines hybrides d'albumine
CA2437272A1 (fr) * 2001-02-06 2002-08-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung Erythropoietine (epo) modifiee a immunogenicite reduite
WO2002070009A1 (fr) * 2001-02-27 2002-09-12 Yasuda, Yoshiko Medicaments preventifs/curatifs pour cicatrices hypertrophiques, cheloides et maladies arthritiques chroniques
CA2446739A1 (fr) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Proteines hybrides beta-1 de chimiokine
US7045546B2 (en) * 2001-07-26 2006-05-16 Tagra Biotechnologies Ltd. Stabilized derivatives of ascorbic acid-3-phosphate
US6930086B2 (en) 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
WO2004099231A2 (fr) 2003-04-09 2004-11-18 Neose Technologies, Inc. Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes
AU2002364587A1 (en) * 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
EP2261250B1 (fr) * 2001-12-21 2015-07-01 Human Genome Sciences, Inc. Protéines de fusion d'albumine et GCSF
PL372862A1 (en) * 2002-08-09 2005-08-08 Merck Patent Gmbh T-cell epitopes in erythropoietin
EP1594530A4 (fr) 2003-01-22 2006-10-11 Human Genome Sciences Inc Proteines hybrides d'albumine
CA2521273A1 (fr) * 2003-04-02 2004-10-21 Epimmune Inc. Peptides, polypeptides et proteines d'immunogenicite reduite et leurs procedes de production
US20040266993A1 (en) * 2003-06-30 2004-12-30 Evans Glen A. Non-immunoglobulin binding polypeptides
US7588745B2 (en) * 2004-04-13 2009-09-15 Si Options, Llc Silicon-containing products
US20050255112A1 (en) * 2004-05-17 2005-11-17 Lee Jong Y Compositions and methods for preventing erythropoietin-associated hypertension
MX2007005640A (es) * 2004-11-10 2007-08-14 Aplagen Gmbh Moleculas que promueven la hematopoyesis.
KR20070092706A (ko) * 2004-11-10 2007-09-13 아플라겐 게엠베하 조혈을 촉진하는 분자
US7589063B2 (en) * 2004-12-14 2009-09-15 Aplagen Gmbh Molecules which promote hematopoiesis
EP1848461A2 (fr) * 2005-02-16 2007-10-31 Nektar Therapeutics Al, Corporation Conjugues d'une fraction d'epo et d'un polymere
US8329652B2 (en) * 2005-05-10 2012-12-11 Neoloch Aps Neuritogenic peptides
EP1736481A1 (fr) * 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Variants d'érythropoietine
EP1907417A2 (fr) * 2005-06-23 2008-04-09 AplaGen GmbH Composes supravalents
PT2540309T (pt) 2005-08-05 2017-12-29 Araim Pharmaceuticals Inc Péptidos protectores de tecidos e suas utilizações
WO2007101698A2 (fr) * 2006-03-09 2007-09-13 Aplagen Gmbh Molecules modifiees destinees a promouvoir l'hematopoiese
EP2134862A4 (fr) * 2007-03-12 2011-04-20 Univ Utah Res Found Compositions et procedes pour le diagnostic et le traitement de complications microvasculaires diabetiques
SG188161A1 (en) 2008-01-22 2013-03-28 Araim Pharmaceuticals Inc Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
CA2712606A1 (fr) 2008-02-08 2009-08-13 Ambrx, Inc. Polypeptides leptine modifies et leurs utilisations de marburg
CN102232085A (zh) 2008-09-26 2011-11-02 Ambrx公司 修饰的动物促红细胞生成素多肽和其用途
KR102233664B1 (ko) * 2012-12-05 2021-04-02 노파르티스 아게 Epo를 표적화하는 항체에 대한 조성물 및 방법
ES2913530T3 (es) 2015-08-12 2022-06-02 Novartis Ag Métodos para tratar trastornos oftálmicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4558005A (en) * 1982-09-13 1985-12-10 University Patents, Inc. Monoclonal anti-erythropoietin
US4558006A (en) * 1983-02-04 1985-12-10 Kirin-Amgen, Inc. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions

Also Published As

Publication number Publication date
JP3155002B2 (ja) 2001-04-09
DE59010787D1 (de) 1998-02-05
US5106954A (en) 1992-04-21
US5712370A (en) 1998-01-27
CA2021912C (fr) 2001-11-27
ATE161577T1 (de) 1998-01-15
PT94813A (pt) 1991-03-20
CA2021912A1 (fr) 1991-01-27
KR0175657B1 (ko) 1999-04-01
DE3924746A1 (de) 1991-01-31
EP0410246A1 (fr) 1991-01-30
IE902707A1 (en) 1991-02-27
AU648506B2 (en) 1994-04-28
AU5977890A (en) 1991-01-31
KR910002897A (ko) 1991-02-26
EP0410246B1 (fr) 1997-12-29
ES2111524T3 (es) 1998-03-16
PT94813B (pt) 1997-04-30
GR3026096T3 (en) 1998-05-29
JPH0381294A (ja) 1991-04-05

Similar Documents

Publication Publication Date Title
DK0410246T3 (da) Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.
ES2082775T3 (es) Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos.
WO1996029605A3 (fr) Composes et methodes de depistage de l'infection par trypanosoma cruzi
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
SG50681A1 (en) Method for the production of monoclonal antibodies utilizing a germfree animal
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
DK556689D0 (da) Antistof-konjugater, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende disse
NO910209D0 (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18 antistoffer.
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE397659T1 (de) Polyklonale antikörper gegen den menschlichen alpha-pdgf-rezeptor und dessen verwendung
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
GR3007000T3 (fr)
DE69228739D1 (de) Immunoassay und monoklonaler antikörper zum nachweis von diarrhetischem schalentiergift
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
NO974852L (no) Humant <beta>2-integrin-<alfa>-subenhet
NO890116L (no) Monoklonale antistoffer.
NO305867B1 (no) FremgangsmÕte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
RU96119723A (ru) Способ выявления т-зависимого иммунодефицита
ZA903854B (en) Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
NO912192L (no) Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
NO890775D0 (no) Apparat for testing av utblaasningssikring.
DK27991D0 (da) Telefon med sensorer for human test, og transmitteret isaer via isdn-net
SE8600543D0 (sv) Diagnostiskt test for detektering av antikroppar i kroppsvetskor
DE69113923D1 (de) Quantitatives Analysenverfahren und dazugehörendes, mit einem Wegwerffühler versehenes System.